COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020 07; 21(7):914-922.